Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company that manufactures and sells various types of medicine in mainland China.[1] It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair.[2] Zhong and her family own 66% of the company.[3] It is the largest psychotropic drug producer in China.[4]
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange on 14 June 2019.[5][6][7][8]
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index.[9]
See also
- Jiangsu Hengrui Medicine
External links
References
- 翰森製藥集團有限公司簡介 retrieved 2020-03-29^
- 翰森製藥集團有限公司發展歷程 retrieved 2020-03-29^
- Hang Seng review shines light on China’s 6th richest woman at Hansoh Pharma South China Morning Post, 22 August 2022, retrieved 6 January 2023^
- Chem teacher behind pharmaceutical firm to be China’s third-richest woman South China Morning Post, 13 June 2019, retrieved 6 January 2023^
- 翰森製藥入場費逾2.88萬元 2019-05-30^
- 翰森製藥超購11倍 信報, 2019-06-13^
- 翰森製藥集團有限公司招股公告 retrieved 2020-03-29^
- 翰森製藥集團有限公司招股資料 retrieved 2020-03-29^
- Baidu, Shenhua Energy to join Hang Seng Index as members rise to 73 stocks South China Morning Post, 19 August 2022, retrieved 6 January 2023^